SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is currently seeing intense volatility and bearish pressure as traders brace for upcoming FDA briefing documents and the subsequent advisory committee vote on its Duchenne muscular dystrophy therapy. The community remains deeply divided, with bulls pointing to the trial's statistical significance and potential patient impact, while bears highlight regulatory skepticism and pending legal challenges as major points of concern.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SPCX is seeing high volatility and intense social media debate as investors weigh the company's long-term potential against concerns over valuation, upcoming share lock-up expirations, and the impact of recent Starship launch results. While some community members are actively accumulating shares on dips, others are focusing on bearish sentiment driven by high short interest and questions regarding the stock's long-term sustainability.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors weigh an expanded partnership with AT&T against broader macro-driven volatility in high-beta tech stocks. While the community remains divided over valuation and the potential for a short-term pullback, bulls are highlighting recent government support and enterprise adoption as key indicators for long-term growth.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors digest executive orders aimed at accelerating U.S. quantum technology leadership and strengthening national security. While bulls highlight potential government funding and strategic importance, bears are actively debating the company's high cash burn rates, recent insider selling, and extreme valuation multiples relative to current enterprise revenue.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors weigh strong U.S. commercial potential against recent volatility, fueled by the upcoming CHMP opinion on Yartemlea and a strategic buyback of convertible notes. Community discussion remains polarized between bullish sentiment regarding the drug's FDA-approved status and competitive positioning versus concerns over transparency, pipeline execution, and the departure of key executives.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing extreme volatility and heavy selling pressure as traders react to broad sector weakness, global geopolitical tensions, and pre-earnings de-risking. The community remains deeply divided, with bulls pointing to strong AI-driven fundamentals and upcoming company events as reasons to accumulate, while bears are actively highlighting the stock's breakdown in price action and shifting sentiment regarding memory supply cycles.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is drawing significant market attention following a massive $500 billion partnership with SK Group to secure next-generation memory supply and data center infrastructure, alongside discussions to backstop large-scale OpenAI data center financing. Investors are actively debating the sustainability of this aggressive infrastructure spending cycle, weighing the company's long-term enterprise demand against concerns regarding financing structures and potential market saturation.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is experiencing extreme volatility and intense community debate surrounding its valuation relative to its Net Asset Value, fueled by the upcoming expiration of a lockup period for restricted shares. Traders are actively speculating on the fund's exposure to high-profile AI and aerospace companies while clashing over the discrepancy between current market prices and the underlying portfolio holdings.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to significant leadership changes, with the CEO stepping down amid a period of strong sales growth for its lead therapy, Carvykti. The community is actively debating whether this transition, alongside recent stock price volatility, signals an imminent buyout by partner Johnson & Johnson or a strategic shift to bolster its competitive position in the crowded multiple myeloma space.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending following a definitive agreement to be acquired by Argenx in an all-cash transaction. The community is actively discussing the deal premium, the company's valuation, and the broader momentum in the immunology and biotech sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RVI what a shit upgrade to NAV. Better have another adjustment soon

StockTwits for iOS

Robinhood Ventures Fund I - Common shares of beneficial interest

 what a shit upgrade to NAV. Better have another adjustment soon